Our findings suggest that nicotine may exert neuroprotective effects in Parkinson’s disease by improving mitochondrial function and enhancing energetic metabolism, potentially via activation of the PI3K-AKT-mTOR pathway. This evidence concerns the gene MTOR and Parkinson disease.